rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2007-9-14
|
pubmed:abstractText |
The efficacy of different formulations of the naphthoquinone buparvaquone and two phosphate prodrugs in in vivo models of both visceral and cutaneous leishmaniasis is described.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0305-7453
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
60
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
802-10
|
pubmed:meshHeading |
pubmed-meshheading:17715126-Animals,
pubmed-meshheading:17715126-Antiprotozoal Agents,
pubmed-meshheading:17715126-Chemistry, Pharmaceutical,
pubmed-meshheading:17715126-Female,
pubmed-meshheading:17715126-Leishmania donovani,
pubmed-meshheading:17715126-Leishmania major,
pubmed-meshheading:17715126-Leishmaniasis, Cutaneous,
pubmed-meshheading:17715126-Leishmaniasis, Visceral,
pubmed-meshheading:17715126-Liver,
pubmed-meshheading:17715126-Mice,
pubmed-meshheading:17715126-Mice, Inbred BALB C,
pubmed-meshheading:17715126-Naphthoquinones,
pubmed-meshheading:17715126-Prodrugs,
pubmed-meshheading:17715126-Skin
|
pubmed:year |
2007
|
pubmed:articleTitle |
In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs.
|
pubmed:affiliation |
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK. t.garnier@herts.ac.uk
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|